OVV

Ovintiv Inc.

Stock · NYSE

Program summary

FieldValueAs ofSource
Current authorization$3.1bnEST30-Sep-2610-Q filed 03-Nov-26
Remaining authorizationNot found in filings—
Program expiry02-Oct-2630-Sep-2610-Q filed 03-Nov-26
Repurchased last quarter$386m30-Sep-2610-Q filed 03-Nov-26
Has used an ASRNo—

Programs

Authorized onAuthorizedRemainingExpiresTerms
01-Oct-26$1.7bnEST
27.0m sh
Not found in filings04-Oct-27On October 1, 2026, Ovintiv announced it had received regulatory approval to purchase, for cancellation or return to treasury, up to approximately 27.0 million shares of common stock pursuant to a NCIB over a 12-month period from October 5, 2026, and ending October 4, 2027.10-Q filed 03-Nov-26
29-Sep-25$1.4bnEST
22.3m sh
$534mEST
8.4m sh left
02-Oct-26On September 29, 2025, Ovintiv announced it had received regulatory approval to purchase, for cancellation or return to treasury, up to approximately 22.3 million shares of common stock pursuant to a NCIB over a 12-month period from October 3, 2025, and ending October 2, 2026.10-Q filed 03-Nov-26

Open-market repurchases

Repurchased per month, USD (≈ shares × average price)
  1. Apr ’26
  2. May ’26
  3. ≈$158m
    Jun ’26
  4. Jul ’26
  5. Aug ’26
  6. ≈$104m
    Sep ’26
Month endedSharesAvg price≈ ValueSource
30-Sep-261,659,544$62.76$104m10-Q filed 03-Nov-26
31-Aug-262,417,863$62.61$151m10-Q filed 03-Nov-26
31-Jul-262,255,144$57.71$130m10-Q filed 03-Nov-26
30-Jun-262,844,037$55.41$158m10-Q filed 23-Jul-26
Filings through 30-Sep-26· checked 18-Nov-26